Small-molecule inhibitor of HlyU attenuates virulence of Vibrio species. 2019

Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
National Research Laboratory of Molecular Microbiology and Toxicology, Department of Agricultural Biotechnology and Center for Food Safety and Toxicology, Seoul National University, Seoul, 08826, South Korea.

Increasing antibiotic resistance has led to the development of new strategies to combat bacterial infection. Anti-virulence strategies that impair virulence of bacterial pathogens are one of the novel approaches with less selective pressure for developing resistance than traditional strategies that impede viability. In this study, a small molecule CM14 [N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide] that inhibits the activity of HlyU, a transcriptional regulator essential for the virulence of the fulminating human pathogen Vibrio vulnificus, has been identified. Without affecting bacterial growth or triggering the host cell death, CM14 reduces HlyU-dependent expression of virulence genes in V. vulnificus. In addition to the decreased hemolysis of human erythrocytes, CM14 impedes host cell rounding and lysis caused by V. vulnificus. Notably, CM14 significantly enhances survival of mice infected with V. vulnificus by alleviating hepatic and renal dysfunction and systemic inflammation. Biochemical, mass spectrometric, and mutational analyses revealed that CM14 inhibits HlyU from binding to target DNA by covalently modifying Cys30. Remarkably, CM14 decreases the expression of various virulence genes of other Vibrio species and thus attenuates their virulence phenotypes. Together, this molecule could be an anti-virulence agent against HlyU-harboring Vibrio species with a low selective pressure for the emergence of resistance.

UI MeSH Term Description Entries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance
D037521 Virulence Factors Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486) Pathogenicity Factor,Pathogenicity Factors,Virulence Factor,Factor, Pathogenicity,Factor, Virulence,Factors, Pathogenicity,Factors, Virulence
D041261 Vibrio vulnificus A species of halophilic bacteria in the genus VIBRIO, which lives in warm SEAWATER. It can cause infections in those who eat raw contaminated seafood or have open wounds exposed to seawater.

Related Publications

Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
October 2005, Science (New York, N.Y.),
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
January 2018, Frontiers in cellular and infection microbiology,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
June 2023, mBio,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
August 1993, Molecular microbiology,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
November 2013, Infection and immunity,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
June 2018, Molecules (Basel, Switzerland),
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
July 2020, Cell chemical biology,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
November 2006, BMC structural biology,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
March 2023, Molecular therapy. Nucleic acids,
Zee-Won Lee, and Byoung Sik Kim, and Kyung Ku Jang, and Ye-Ji Bang, and Suhyeon Kim, and Nam-Chul Ha, and Young Hyun Jung, and Hyun Jik Lee, and Ho Jae Han, and Jong-Seo Kim, and Jeesoo Kim, and Pramod K Sahu, and Lak Shin Jeong, and Myung Hee Kim, and Sang Ho Choi
February 2021, Clinical and translational medicine,
Copied contents to your clipboard!